Sponsor:
University of Virginia
Code:
NCT05860725
Conditions
Human Papillomavirus Infection
Vaccination Hesitancy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
PSA Development
HPV vaccination focused social marketing campaign
Brief summary:
Conditions
Human Papillomavirus Infection
Vaccination Hesitancy
Study ID
NCT05860725
Start date
Mar 13, 2023
Status verified date
May, 2024
Completion date
May 30, 2024
Anticipated
Primary completion date
May 30, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
220 participants
Anticipated
Allocation
Non randomized
Intervention Model
Single group
Primary purpose
Health Services Research
Arms
experimental: PSA Development (Phase 1)
experimental: Social Marketing Campaign (Phase 2)
no intervention: Organizational Stakeholders
Interventions
PSA Development
HPV vaccination focused social marketing campaign
Primary outcome measure
Central contacts
Locations
University of Virginia
Recruiting
Charlottesville, Virginia, United States, 22903
Contacts
Sponsor
University of Virginia
Last update posted
May 9, 2024
Last verified
May, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Virginia on 2024-05-09.